Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
Reuters
Nov 04, 2025
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
Nov 4 (Reuters) - Novo Nordisk NOVOb.CO is now offering up to $10 billion for Metsera MTSR.O, up from its prior offer of up to $8.5 billion, the obesity drug developer said on Tuesday.
(Reporting by Christy Santhosh and Siddhi Mahatole in Bengaluru; Editing by Maju Samuel)
((Christy.Santhosh@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.